Medium-volume facial lipofilling is a minimally invasive, regenerative aesthetic procedure indicated for the correction of moderate facial volume loss using autologous adipose tissue.

The procedure involves:

• Harvesting of adipose tissue from a donor site.

• Processing and purification of the collected fat.

• Injection of moderate volumes into targeted facial anatomical regions.

This approach allows for:

• Improvement in facial contour and volumetric balance.

• Restoration of proportional harmony between facial features.

Clinical effects include:

• Enhancement of facial symmetry and definition.

• Support of skin regeneration and long-term rejuvenation.

Clinical advantages include:

• Use of autologous tissue, ensuring high biocompatibility.

• Natural-looking and durable results.

Medium-Volume Facial Lipofilling – Postoperative Recovery and Travel Recommendations

Following medium-volume facial lipofilling, patients may experience:

• Postoperative edema and ecchymosis during the initial 2–3 weeks.

• Temporary limitation of daily activities.

Clinical course:

• Gradual improvement over 4–6 weeks as healing progresses.

• Final result stabilization may take several months.

Postoperative recommendations include:

• Remaining in the country for at least 10–14 days following the procedure.

• Avoidance of air travel and short-distance travel (up to 3 hours) during this period.

For extended travel:

• Journeys exceeding 4–6 hours should be postponed for at least 21 days.

• This recommendation is intended to support proper recovery and reduce the risk of postoperative complications.